BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802
373 results:

  • 1. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells.
    Liu Y; Zhang S; Tan Y
    Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223
    [No Abstract]    [Full Text] [Related]  

  • 2. Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
    Tan Q; Gao R; Zhang X; Yang J; Xing P; Yang S; Wang D; Wang G; Wang S; Yao J; Zhang Z; Tang L; Yu X; Han X; Shi Y
    Cancer Immunol Immunother; 2024 Feb; 73(3):47. PubMed ID: 38349411
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CDK6: an attractive therapeutic target for T-ALL/LBL.
    Li W; Hu JK; Hu MG
    Expert Opin Ther Targets; 2023; 27(11):1087-1096. PubMed ID: 37975616
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells.
    Feng Q; Hu K; Hu H; Lu Y; Zhang H; Wang G; Zhang Q; Xu Z; Gao X; Jia X; Zhu H; Song D; Yi H; Peng Y; Wu X; Li B; Zhu W; Shi J
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111139. PubMed ID: 37913572
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Efficacy and Safety of Etoposide Combined with Cyclophosphamide for Autologous Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma].
    Tu ST; Zhou YL; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1410-1414. PubMed ID: 37846692
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways.
    Zhang Y; Wang ZZ; Han AQ; Yang MY; Zhu LX; Pan FM; Wang Y
    Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):195-209. PubMed ID: 37806848
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma.
    Forberg AL; Unrau J; Weber KS; Rutz AC; Lund S; Guidinger J; Pelzel A; Hauge J; Hemmen AJ; Hartert KT
    Ann Hematol; 2024 Jan; 103(1):199-209. PubMed ID: 37792064
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1).
    Raetz EA; Teachey DT; Minard C; Liu X; Norris RE; Denic KZ; Reid J; Evensen NA; Gore L; Fox E; Loh ML; Weigel BJ; Carroll WL
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30609. PubMed ID: 37553297
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incidence and Features of Lymphoid Proliferation and lymphomas after Solid Organ or Hematopoietic Stem Cell Transplantation in a National Database Cohort.
    Hahn SM; Lee M; Hyun J; Lim S; Kang JM; Ahn JG; Joo DJ; Jung I; Ihn K
    Cancer Res Treat; 2024 Jan; 56(1):305-313. PubMed ID: 37475137
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia.
    Cao L; Ruiz Buendía GA; Fournier N; Liu Y; Armand F; Hamelin R; Pavlou M; Radtke F
    Blood Adv; 2023 Oct; 7(20):6240-6252. PubMed ID: 37358480
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Ambra1 modulates the sensitivity of mantle cell lymphoma to palbociclib by regulating cyclin D1.
    Jiang Z; Zhang A; Wei W; Li S
    Sci Rep; 2023 May; 13(1):8389. PubMed ID: 37225761
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia.
    Patel J; Gao X; Wang H
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108359
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia.
    Wilde L; Porazzi P; Trotta R; De Dominici M; Palmisiano N; Keiffer G; Rancani K; Yingling K; Calabretta B; Kasner M
    Leuk Res; 2023 Jun; 129():107075. PubMed ID: 37079999
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells.
    Xie X; Zhang W; Zhou X; Ye Z; Wang H; Qiu Y; Pan Y; Hu Y; Li L; Chen Z; Yang W; Lu Y; Zou S; Li Y; Bai X
    Br J Haematol; 2023 Jun; 201(5):940-953. PubMed ID: 36916190
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Assessment of Social Vulnerability in Pediatric Head and Neck Cancer Care and Prognosis in the United States.
    Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [In vitro pharmacodynamic studies of novel class Ⅰ and Ⅱb selective histone deacetylase inhibitor purinostat mesylate in the treatment of diffuse large B-cell lymphoma and its mechanism].
    Wang J; Zhao AL; Li H; Yang LY; Chen LJ; Niu T
    Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):753-759. PubMed ID: 36709169
    [No Abstract]    [Full Text] [Related]  

  • 18. Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting cdk4 transcription for malignancies.
    Mei H; Wu H; Yang J; Zhou B; Wang A; Hu C; Qi S; Jiang Z; Zou F; Wang B; Liu F; Chen Y; Wang W; Liu J; Liu Q
    Signal Transduct Target Ther; 2023 Jan; 8(1):18. PubMed ID: 36642705
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Induction of Apoptosis via Inactivating PI3K/AKT Pathway in Colorectal Cancer Cells Using Aged Chinese Hakka Stir-Fried Green Tea Extract.
    Zhang X; Huang H; Sun S; Li D; Sun L; Li Q; Chen R; Lai X; Zhang Z; Zheng X; Wong WL; Wen S
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500365
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Cell Cycle Arrest and Apoptosis Induced by Atovaquone in Non-Hodgkin's lymphoma Raji Cells].
    Chen CY; Shen X; Xing S; Zhang XW; Jiang G; Yu ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1746-1751. PubMed ID: 36476898
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.